Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by 백성진, Chairman & CEO. Officer active across 1 company, notably HLB바이오스텝. Cumulatively, 3 disclosures have been recorded. Activity tracked since 29 May 2026. The latest transaction was disclosed on 29 May 2026 (Purchase). Regulator: DART (FSS). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Baek Seong-jin is the Chairman & CEO of HLB바이오스텝. He leads the company by implementing innovative strategies and overseeing daily operations. His expertise is a major asset for the company's growth.